Medicare Part D Basics and Policy Options for Redesign


Juliette Cubanski, Ph.D., MPP, MPH
KFF, Deputy Director, Program on Medicare Policy

Sarah J. Dash, MPH
Alliance for Health Policy, President and Chief Executive Officer

Stacie Dusetzina, Ph.D.
Vanderbilt University School of Medicine, Associate Professor of Health Policy, Associate Professor of Cancer Research

Leigh Purvis, MPA
AARP, Director, Health Care Costs and Access

Experts and Analysts

Kirsten Axelsen, M.S.
American Enterprise Institute, Visiting Fellow

Kelly Brantley, MPH
Avalere, Policy Practice Director

Lovisa Gustafsson, MBA
The Commonwealth Fund, Vice President, Controlling Health Care Costs

Adam J. Fein, Ph.D.
Drug Channels Institute, Chief Executive Officer

Mark McCLellan, M.D., Ph.D.
Duke-Margolis Center for Health Policy, Robert J. Margolis Professor of Business, Medicine, and Policy and Founder

Kristi Martin, MPA
Highway 136 Consulting, President

Andrea Noda, MPP
Director of Health Care, Arnold Ventures


John Coster, Ph.D., R.Ph.
Centers for Medicare & Medicaid Services, Director, Division of Pharmacy at Center for Medicaid and CHIP Services

Andi Lipstein Fristedt, MPA
U.S. Food and Drug Administration, Deputy Commissioner for Policy, Legislation, and International Affairs


Kristin Bass, MBA
Pharmaceutical Care Management Association, Chief Policy and External Affairs Officer

Lida Etemad, Pharm.D., M.S.
United Healthcare Pharmacy, Vice President, Pharmacy Management Strategies

Mark Howell, J.D.
American Hospital Association, Senior Associate Director, Standards and Drug Policy

David Mitchell
Patients for Affordable Drugs, President and Founder

John O’Brien, Pharm.D., MPH
National Pharmaceutical Council, President and Chief Executive Officer

Return to event page »